Skip to search formSkip to main contentSkip to account menu

tifluadom

Known as: 1-methyl-2-(3-thienylcarbonyl)aminomethyl-5-(2-fluorophenyl)-H-2,3-dihydro-1,4-benzodiazepine, 3-Thiophenecarboxamide, N-((5-(2-fluorophenyl)-2,3-dihydro-1-methyl-1H-1,4-benzodiazepin-2-yl)methyl)-, titfluadom 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1997
Highly Cited
1997
Activation of kappa receptors inhibits adenylate cyclase, enhances K+ conductance and reduces Ca++ conductance via pertussis… 
Highly Cited
1989
Highly Cited
1989
Kappa receptor multiplicity is a complex area. We now present evidence from binding studies suggesting the existence of four… 
Highly Cited
1988
Highly Cited
1988
We studied the effect of opiates acting preferentially on mu receptors, like morphine, methadone and fentanyl (mu agonists) and… 
Highly Cited
1987
Highly Cited
1987
The effects of the kappa agonists bremazocine, ethylketazocine, tifluadom and U-50,488 were examined in rhesus monkeys with four… 
Highly Cited
1983
Highly Cited
1982
Highly Cited
1982
Although the benzodiazepines have been extensively investigated since their discovery about 20 years ago1, only recently have… 
Highly Cited
1982